Revenue
2021
2022
2023
MindMaze Therapeutics Holding SA (MMTZF)
Price$0.2000Cached quote
Financial statements
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Revenue | CHF6.3M | CHF7.1M | CHF4.5M |
| Research & development | CHF1.3M | CHF12.4M | CHF19.0M |
| Operating income | −CHF110.8M | −CHF52.0M | −CHF34.3M |
| Operating margin | −1,751.39% | −731.93% | −763.71% |
| EBITDA | −CHF107.5M | −CHF48.2M | −CHF32.3M |
| EBITDA margin | −1,698.96% | −677.64% | −718.39% |
| Net income | −CHF98.2M | −CHF50.8M | −CHF34.7M |
| Net profit margin | −1,551.53% | −714.35% | −772.60% |
| Basic EPSper basic share | -CHF 8.35 | -CHF 4.81 | -CHF 0.01 |
| Diluted EPSper diluted share | -CHF 8.35 | -CHF 4.81 | -CHF 0.01 |